Serum IgA, IgG, and IgM concentrations in patients with epilepsy and matched controls: A cohort-based cross-sectional study

Epilepsy and Behavior

Volumn 6, Issue 2, 2005, Pages 191-195

  Ranua, Jouni ^a   Luoma, Katja ^b   Auvinen, Anssi ^c   Peltola, Jukka ^d   Haapala, Anna Maija ^d   Raitanen, Jani ^c   Isojärvi, Jouko ^b  

^a SEINÄJOKI CENTRAL HOSPITAL   (Finland)

^b UNIVERSITY OF OULU   (Finland)

^c UNIVERSITY OF TAMPERE   (Finland)

^d TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

Antiepileptic medication; Autoantibodies; Autoimmune diseases; Epilepsy; Immunoglobulin A; Immunoglobulin G; Immunoglobulin M

Indexed keywords

CARBAMAZEPINE; CLONAZEPAM; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LAMOTRIGINE; OXCARBAZEPINE; PHENYTOIN; VALPROIC ACID;

ADULT; ANTICONVULSANT THERAPY; ARTICLE; AUTOIMMUNE DISEASE; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DISEASE COURSE; DRUG EFFECT; DRUG MECHANISM; DRUG USE; EPILEPSY; FEMALE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; ONSET AGE; PREVALENCE; SEX DIFFERENCE;

ANTICONVULSANTS; CASE-CONTROL STUDIES; COHORT STUDIES; CONFIDENCE INTERVALS; CROSS-SECTIONAL STUDIES; EPILEPSY; FEMALE; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LINEAR MODELS; MALE; ODDS RATIO; PREVALENCE;

EID: 13844267571     PISSN: 15255050     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yebeh.2004.11.017     Document Type: Article

References (25)

1. R. Mantegazza P. Bernasconi F. Baggi et al. Antibodies against GluR3 peptides are not specific for Rasmussen's encephalitis but are also present in epilepsy patients with severe, early onset disease and intractable seizures J Neuroimmunol 131 2002 179-185
2. F. Villani G. Avanzini The use of immunoglobulins in the treatment of human epilepsy Neurol Sci 23 2002 33-37
3. D. Verrot M. San-Marco C. Dravet et al. Prevalence and significance of antinuclear and anticardiolipin antibodies in patients with epilepsy Am J Med 103 1997 33-37
4. J.T. Peltola A.M. Haapala J.I. Isojärvi et al. Antiphospholipid and antinuclear antibodies in patients with epilepsy or new-onset seizure disorders Am J Med 109 2000 712-717
5. K. Eriksson J. Peltola T. Keränen A.M. Haapala M. Koivikko High prevalence of antiphospholipid antibodies in children with epilepsy: A controlled study of 50 cases Epilepsy Res 46 2000 129-137
6. J. Ranua K. Luoma J. Peltola et al. Anticardiolipin and antinuclear antibodies in epilepsy: A population based cross-sectional study Epilepsy Res 58 2004 13-18
7. J. Peltola P. Kulmala J. Isojarvi et al. Autoantibodies to glutamatic acid decarboxylase in patients with therapy-resistant epilepsy Neurology 55 2000 46-50
8. J.A. Aarli Immunological aspects of epilepsy Brain Dev 15 1993 41-50
9. J.A. Aarli Epilepsy and the immune system Arch Neurol 57 2000 1689-1692
10. P. Andersen L. Mosekilde Immunoglobulin levels and autoantibodies in epileptics on long-term anticonvulsant therapy Acta Med Scand 201 1977 69-74
11. E.J. Bardana J.D. Gabourel G.H. Davies S. Craig Effects of phenytoin on man's immunity Am J Med 74 1983 289-296
12. F. Ponti S. Lecchini M. Cosentino C.M. Castelletti A. Malesci G.M. Frigo Immunological adverse effects of anticonvulsants Drug Saf 3 1993 235-250
13. N. Basaran F. Hincal E. Kansu A. Ciger Humoral and cellular immune parameters in untreated and phenytoin or carbamazepine-treated epileptic patients Int J Immunopharmacol 16 1994 1071-1077
14. S.R. Knowles L.E. Shapiro N.H. Shear Anticonvulsant hypersensitivity syndrome Drug Saf 21 1999 489-501
15. R. Pacifici L. Paris S. Di Carlo S. Pichini P. Zuccaro Immunological aspects of carbamazepine treatment in epileptic patients Epilepsia 32 1991 122-127
16. T.C. Sorrell I.J. Forbes Depression of immune competence by phenytoin and carbamazepine Clin Exp Immunol 20 1975 273-285
17. S. Bostantjopoulou O. Hatzizisi O. Argyropoulou et al. Immunological parameters in patients with epilepsy Funct Neurol 9 1994 11-15
18. O. Eeg-Olofsson C.K. Osterland R.D. Guttmann et al. Immunological studies in focal epilepsy Acta Neurol Scand 78 1988 358-368
19. N.E. Gilhus T. Lea IgG subclasses in epileptic patients treated with phenytoin J Neurol 236 1989 149-152
20. Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for revised clinical and electroencephaliographic classification of epileptic seizures. Epilepsia 1989;30:389-99
21. N.E. Gilhus J.A. Aarli The reversibility of phenytoin-induced IgA deficiency J Neurol 226 1981 53-61
22. R.S. Pereira J. Allen J. Oxley Analysis of B lymphocyte function in drug induced immunoglobulin deficiency. In: J. Oxley D. Janz H. Meinardi editors. Chronic toxicity of antiepileptic drugs 1983 Raven Press New York 269-274
23. O. Eeg-Olofsson Virological and immunological aspects of seizure disorders Brain Dev 25 2003 9-13
24. J. Peltola J. Palmio L. Korhonen et al. Interleukin-6 and interleukin-1 receptor antagonist in cerebrospinal fluid from patients with recent tonic-clonic seizures Epilepsy Res 42 2000 201-211
25. Gilhus NE, Aarli JA. Respiratory disease and nasal immunoglobulin concentrations in phenytoin-treated epileptic patients. Acta Neurol Scand 1977;56:353-6